Autoimmune hepatitis

The U.S. Food and Drug Administration ( FDA ) has approved the combination of Keytruda ( Pembrolizumab ), an anti-PD-1...



Opdivo ( Nivolumab ) 3 mg/kg plus Yervoy ( Ipilimumab ) 1 mg/kg ( injections for intravenous use ) was...



The FDA ( U.S. Food and Drug Administration ) has approved Keytruda ( Pembrolizumab ), an anti-PD-1 therapy, in combination...


The FDA ( U.S. Food and Drug Administration ) has approved Keytruda ( Pembrolizumab ), the anti-PD-1 ( programmed death...


The viruses hepatitis B and C may both be associated with an increased risk of Parkinson’s disease, according to a...


Researchers have conducted a study to analyze how infection by hepatitis C virus ( HCV ) may influence the immunological...


Keytruda ( Pembrolizumab ) is indicated in the United States at a dose of 2 mg/kg administered as an intravenous infusion over...


Keytruda ( Pembrolizumab ) is a humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and...


Forty percent of patients with autoimmune hepatitis ( AIH ) present with acute jaundice / hepatitis. Such patients, when treated...


The European Commission ( EC ) has granted marketing authorization for Plegridy ( Peginterferon beta-1a ) as a treatment for...


Rituximab ( MabThera, Rituxan ) is a chimeric murine/human monoclonal antibody that specifically targets CD20 molecules on the surface of...


In the SELECT trial, disease activity was reduced in patients with multiple sclerosis who received Daclizumab high-yield process ( HYP...


Sovaldi ( Sofosbuvir ) is the first-in-class medicine that provides the first interferon-free treatment option in patients chronic hepatitis C.Hepatitis...


Yervoy ( Ipilimumab ) is indicated for the treatment of unresectable or metastatic melanoma, and can result in severe and...


Orencia ( Abatacept ) SC ( subcutaneous ) and IV ( intravenous ) is indicated for reducing signs and symptoms,...


Stribild contains four compounds in a complete once-daily, single tablet regimen: Elvitegravir 150 mg; Cobicistat 150 mg; Emtricitabine 200 mg;...


Two clinical trials of Humira ( Adalimumab ), REVEAL and CHAMPION, have demonstrated promising results in psoriasis. Psoriasis is a...


A Phase II study of Rituximab ( MabThera, Rituxan ) for relapsing-remitting multiple sclerosis ( RRMS ) met its primary...